Online first
Short communication
Published online: 2024-11-25
Hybrid coronary revascularization in multivessel disease: Long-term clinical outcomes of the prospective randomized study
Abstract
Not available
References
- Writing Co, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022; 79(2): 197–215.
- Vrints C, Andreotti F, Koskinas KC, et al. et al.. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024; 45(36): 3415–3537.
- Gąsior M, Zembala MO, Tajstra M, et al. Hybrid revascularization for multivessel coronary artery disease. JACC Cardiovasc Interv. 2014; 7(11): 1277–1283.
- Tajstra M, Hrapkowicz T, Hawranek M, et al. Hybrid coronary revascularization in selected patients with multivessel disease: 5-year clinical outcomes of the prospective randomized pilot study. JACC Cardiovasc Interv. 2018; 11(9): 847–852.
- Sanetra K, Buszman PP, Jankowska-Sanetra J, et al. Safety and feasibility of minimally invasive coronary artery bypass surgery early after drug-eluting stent implantation due to acute coronary syndrome. Kardiol Pol. 2023; 81(5): 482–490.
- Zembala M, Tajstra M, Zembala M, et al. Prospective randomised pilOt study evaLuating the safety and efficacy of hybrid revascularisation in MultI-vessel coronary artery DisEaSe (POLMIDES) - study design. Kardiol Pol. 2011; 69(5): 460–466.
- Fitzpatrick T, Perrier L, Shakik S, et al. Assessment of long-term follow-up of randomized trial participants by linkage to routinely collected data: A scoping review and analysis. JAMA Netw Open. 2018; 1(8): e186019.
